Search results
Jump to navigation
Jump to search
Google site results
Loading...
Wiki results
- ...>Diaz JI, Mora LB, Hakam A. The Mainz Classification of Renal Cell Tumors. Cancer Control. 1999 Nov;6(6):571-579</ref> ...ton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 8;26(3):319-30.</ref>3 KB (421 words) - 11:29, 22 August 2016
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==11 KB (1,435 words) - 13:46, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==13 KB (1,816 words) - 14:00, 3 November 2023
- ...Table derived from Pugh et al., 2018 [PMID 30393007] with permission from Cancer Genetics. |'''Genes'''17 KB (2,298 words) - 16:42, 22 April 2021
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==12 KB (1,669 words) - 12:40, 3 November 2023
- ==Cancer Category/Type== ...scular endothelial growth factor (''VEGF'') (Merdzhanova et al., 2010). In cancer, ''SRSF2'' variants have been implicated in leukemia and myeloid disorders16 KB (2,281 words) - 14:50, 12 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,320 words) - 12:39, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==12 KB (1,705 words) - 12:38, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,340 words) - 12:49, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==13 KB (1,711 words) - 16:34, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==12 KB (1,721 words) - 13:49, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,265 words) - 12:54, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,380 words) - 16:33, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,383 words) - 16:39, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,304 words) - 16:43, 4 December 2023
- Patricia V. Hernandez, M.D., Washington University School of Medicine ==Cancer Category/Type==6 KB (814 words) - 12:53, 3 November 2023
- Patricia V. Hernandez, M.D., Washington University School of Medicine ==Cancer Category/Type==6 KB (814 words) - 12:53, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (2,044 words) - 10:09, 27 February 2024
- Thank you for volunteering to help curate the Compendium of Cancer Genome Aberrations (CCGA)! Your help will make this resource a valuable to ...“Disease pages”. The CCGA is especially interested in the curation fusion genes/mutations that arise in disease, esp. in the hematological cancers. Howeve7 KB (1,171 words) - 17:30, 23 April 2019
- ...ed from Kanagal-Shawanna et al., 2018 [PMID 30377088] with permission from Cancer Genetics. ...urvival in a cohort of MDS or AML patients treated with azacitidine. Blood Cancer J 2013;3:e155.[https://www.ncbi.nlm.nih.gov/pubmed/24185502]</ref><ref name38 KB (5,270 words) - 17:10, 30 April 2020
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,651 words) - 14:40, 13 December 2023
- ==Cancer Category/Type== Breast Cancer / Epithelial Tumours of the Breast19 KB (2,737 words) - 13:17, 29 February 2024
- {{DISPLAYTITLE:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged}} ==Cancer Category/Type==6 KB (910 words) - 13:48, 3 November 2023
- Patricia V. Hernandez, M.D., Washington University School of Medicine ==Cancer Category/Type==13 KB (1,772 words) - 12:52, 3 November 2023
- ==Cancer Category/Type== ...ET2 and WT1 physically interact, suggesting overlapping pathways for these genes in AML (Wang et al., 2015). ''TET2'' mutations increase the response of low26 KB (3,824 words) - 15:01, 12 December 2023
- Patricia V. Hernandez, M.D., Washington University School of Medicine ==Cancer Category/Type==13 KB (1,811 words) - 13:58, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==12 KB (1,693 words) - 12:30, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification/Subtype==6 KB (851 words) - 12:46, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==13 KB (1,734 words) - 13:42, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (2,022 words) - 12:31, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==15 KB (2,002 words) - 12:34, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==23 KB (3,226 words) - 12:31, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (1,965 words) - 14:30, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==20 KB (2,766 words) - 12:38, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (889 words) - 11:39, 14 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==23 KB (3,259 words) - 13:43, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==20 KB (2,803 words) - 16:32, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (1,040 words) - 12:57, 3 November 2023
- Patricia V. Hernandez, M.D., Washington University School of Medicine ==Cancer Category / Type==15 KB (2,067 words) - 14:23, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (2,056 words) - 13:43, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (947 words) - 12:55, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (1,946 words) - 16:28, 4 December 2023
- ==Cancer Category/Type== ===Role in Cancer===20 KB (2,904 words) - 03:02, 13 August 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,082 words) - 14:00, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (986 words) - 16:43, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==21 KB (2,882 words) - 12:37, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==21 KB (2,915 words) - 13:48, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==19 KB (2,643 words) - 13:51, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==31 KB (4,325 words) - 13:55, 25 February 2024
- ==General Disease Overview / Description of Cancer Category== ...|first2=Marry M.|last3=Aalbers|first3=Anna M.|last4=Balgobind|first4=Brian V.|last5=Hollink|first5=Iris H. I. M.|last6=Meijerink|first6=Jules P. P.|last7 KB (1,048 words) - 12:35, 3 November 2023